トップキープレーヤーは次のとおりです。
F. Hoffmann La Roche Ltd.
Pfizer, Inc.
Actelion Pharmaceuticals, Inc.
Merck KGaA
Corbus Pharmaceutical Holdings, Inc.
Bayer AG
Gilead Sciences, Inc.
Cumberland Pharmaceuticals Inc
Boehringer Ingelheim
Sanofi
Cytori Therapeutics, Inc.
1 Market Overview
1.1 Scleroderma Diagnostics And Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Corticosteroids
1.2.2 Immunosuppressive Agents
1.2.3 Endothelin Receptor Agonists
1.2.4 Calcium Channel Blockers
1.2.5 PDE-5 Inhibitors
1.2.6 Chelating Agents
1.2.7 Prostacyclin Analogues
1.2.8 Others (H2 Blockers, Proton Pump Inhibitors, ACE Inhibitors etc.)
1.3 Market Analysis by Application
1.3.1 Skin Biopsy
1.3.2 Imaging Techniques
1.3.3 Blood Tests
1.3.4 Electrocardiogram and Echocardiogram
1.3.5 Pulmonary Function Tests
1.4 Market Analysis by Region
1.4.1 United States Market States and Outlook (2015-2028)
1.4.2 Europe Market States and Outlook (2015-2028)
1.4.3 China Market States and Outlook (2015-2028)
1.4.4 Japan Market States and Outlook (2015-2028)
1.4.5 Southeast Asia Market States and Outlook (2015-2028)
1.4.6 India Market States and Outlook (2015-2028)
1.4.7 Brazil Market States and Outlook (2015-2028)
1.4.8 GCC Countries Market States and Outlook (2015-2028)
1.5 Market Dynamics and Development
1.5.1 Merger, Acquisition and New Investment
1.5.2 Market SWOT Analysis
1.5.3 Drivers
1.5.4 Limitations
1.5.5 Opportunities and Development Trends
1.6 Global Scleroderma Diagnostics And Therapeutics Market Size Analysis from 2015 to 2028
1.6.1 Global Scleroderma Diagnostics And Therapeutics Market Size Analysis from 2015 to 2028 by Consumption Volume
1.6.2 Global Scleroderma Diagnostics And Therapeutics Market Size Analysis from 2015 to 2028 by Value
1.6.3 Global Scleroderma Diagnostics And Therapeutics Price Trends Analysis from 2015 to 2028
2 Global Scleroderma Diagnostics And Therapeutics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Scleroderma Diagnostics And Therapeutics (Volume and Value) by Type
2.1.1 Global Scleroderma Diagnostics And Therapeutics Consumption and Market Share by Type (2015-2020)
2.1.2 Global Scleroderma Diagnostics And Therapeutics Revenue and Market Share by Type (2015-2020)
2.2 Global Scleroderma Diagnostics And Therapeutics (Volume and Value) by Application
2.2.1 Global Scleroderma Diagnostics And Therapeutics Consumption and Market Share by Application (2015-2020)
2.2.2 Global Scleroderma Diagnostics And Therapeutics Revenue and Market Share by Application (2015-2020)
2.3 Global Scleroderma Diagnostics And Therapeutics (Volume and Value) by Region
2.3.1 Global Scleroderma Diagnostics And Therapeutics Consumption and Market Share by Region (2015-2020)
2.3.2 Global Scleroderma Diagnostics And Therapeutics Revenue and Market Share by Region (2015-2020)
3 United States Scleroderma Diagnostics And Therapeutics Market Analysis
3.1 United States Scleroderma Diagnostics And Therapeutics Consumption and Value Analysis
3.2 United States Scleroderma Diagnostics And Therapeutics Consumption Volume by Type
3.3 United States Scleroderma Diagnostics And Therapeutics Consumption Structure by Application
4 Europe Scleroderma Diagnostics And Therapeutics Market Analysis
4.1 Europe Scleroderma Diagnostics And Therapeutics Consumption and Value Analysis
4.2 Europe Scleroderma Diagnostics And Therapeutics Consumption Volume by Type
4.3 Europe Scleroderma Diagnostics And Therapeutics Consumption Structure by Application
4.4 Europe Scleroderma Diagnostics And Therapeutics Consumption by Top Countries
4.4.1 Germany Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
4.4.2 UK Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
4.4.3 France Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
4.4.4 Italy Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
4.4.5 Spain Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
4.4.6 Poland Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
4.4.7 Russia Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
5 China Scleroderma Diagnostics And Therapeutics Market Analysis
5.1 China Scleroderma Diagnostics And Therapeutics Consumption and Value Analysis
5.2 China Scleroderma Diagnostics And Therapeutics Consumption Volume by Type
5.3 China Scleroderma Diagnostics And Therapeutics Consumption Structure by Application
6 Japan Scleroderma Diagnostics And Therapeutics Market Analysis
6.1 Japan Scleroderma Diagnostics And Therapeutics Consumption and Value Analysis
6.2 Japan Scleroderma Diagnostics And Therapeutics Consumption Volume by Type
6.3 Japan Scleroderma Diagnostics And Therapeutics Consumption Structure by Application
7 Southeast Asia Scleroderma Diagnostics And Therapeutics Market Analysis
7.1 Southeast Asia Scleroderma Diagnostics And Therapeutics Consumption and Value Analysis
7.2 Southeast Asia Scleroderma Diagnostics And Therapeutics Consumption Volume by Type
7.3 Southeast Asia Scleroderma Diagnostics And Therapeutics Consumption Structure by Application
7.4 Southeast Asia Scleroderma Diagnostics And Therapeutics Consumption by Top Countries
7.4.1 Indonesia Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
7.4.2 Thailand Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
7.4.3 Philippines Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
7.4.4 Malaysia Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
7.4.5 Singapore Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
7.4.6 Vietnam Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
8 India Scleroderma Diagnostics And Therapeutics Market Analysis
8.1 India Scleroderma Diagnostics And Therapeutics Consumption and Value Analysis
8.2 India Scleroderma Diagnostics And Therapeutics Consumption Volume by Type
8.3 India Scleroderma Diagnostics And Therapeutics Consumption Structure by Application
9 Brazil Scleroderma Diagnostics And Therapeutics Market Analysis
9.1 Brazil Scleroderma Diagnostics And Therapeutics Consumption and Value Analysis
9.2 Brazil Scleroderma Diagnostics And Therapeutics Consumption Volume by Type
9.3 Brazil Scleroderma Diagnostics And Therapeutics Consumption Structure by Application
10 GCC Countries Scleroderma Diagnostics And Therapeutics Market Analysis
10.1 GCC Countries Scleroderma Diagnostics And Therapeutics Consumption and Value Analysis
10.2 GCC Countries Scleroderma Diagnostics And Therapeutics Consumption Volume by Type
10.3 GCC Countries Scleroderma Diagnostics And Therapeutics Consumption Structure by Application
10.4 GCC Countries Scleroderma Diagnostics And Therapeutics Consumption Volume by Major Countries
10.4.1 Saudi Arabia Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
10.4.2 United Arab Emirates Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
10.4.3 Qatar Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
10.4.4 Bahrain Scleroderma Diagnostics And Therapeutics Consumption Volume from 2015 to 2020
11 Manufacturers Profiles
11.1 F. Hoffmann La Roche Ltd.
11.1.1 Business Overview
11.1.2 Products Analysis
11.1.3 F. Hoffmann La Roche Ltd. Scleroderma Diagnostics And Therapeutics Sales, Price, Revenue, Gross Margin
11.1.4 F. Hoffmann La Roche Ltd. Scleroderma Diagnostics And Therapeutics Sales by Region
11.2 Pfizer, Inc.
11.2.1 Business Overview
11.2.2 Products Analysis
11.2.3 Pfizer, Inc. Scleroderma Diagnostics And Therapeutics Sales, Price, Revenue, Gross Margin
11.2.4 Pfizer, Inc. Scleroderma Diagnostics And Therapeutics Sales by Region
11.3 Actelion Pharmaceuticals, Inc.
11.3.1 Business Overview
11.3.2 Products Analysis
11.3.3 Actelion Pharmaceuticals, Inc. Scleroderma Diagnostics And Therapeutics Sales, Price, Revenue, Gross Margin
11.3.4 Actelion Pharmaceuticals, Inc. Scleroderma Diagnostics And Therapeutics Sales by Region
11.4 Merck KGaA
11.4.1 Business Overview
11.4.2 Products Analysis
11.4.3 Merck KGaA Scleroderma Diagnostics And Therapeutics Sales, Price, Revenue, Gross Margin
11.4.4 Merck KGaA Scleroderma Diagnostics And Therapeutics Sales by Region
11.5 Corbus Pharmaceutical Holdings, Inc.
11.5.1 Business Overview
11.5.2 Products Analysis
11.5.3 Corbus Pharmaceutical Holdings, Inc. Scleroderma Diagnostics And Therapeutics Sales, Price, Revenue, Gross Margin
11.5.4 Corbus Pharmaceutical Holdings, Inc. Scleroderma Diagnostics And Therapeutics Sales by Region
11.6 Bayer AG
11.6.1 Business Overview
11.6.2 Products Analysis
11.6.3 Bayer AG Scleroderma Diagnostics And Therapeutics Sales, Price, Revenue, Gross Margin
11.6.4 Bayer AG Scleroderma Diagnostics And Therapeutics Sales by Region
11.7 Gilead Sciences, Inc.
11.7.1 Business Overview
11.7.2 Products Analysis
11.7.3 Gilead Sciences, Inc. Scleroderma Diagnostics And Therapeutics Sales, Price, Revenue, Gross Margin
11.7.4 Gilead Sciences, Inc. Scleroderma Diagnostics And Therapeutics Sales by Region
11.8 Cumberland Pharmaceuticals Inc
11.8.1 Business Overview
11.8.2 Products Analysis
11.8.3 Cumberland Pharmaceuticals Inc Scleroderma Diagnostics And Therapeutics Sales, Price, Revenue, Gross Margin
11.8.4 Cumberland Pharmaceuticals Inc Scleroderma Diagnostics And Therapeutics Sales by Region
11.9 Boehringer Ingelheim
11.9.1 Business Overview
11.9.2 Products Analysis
11.9.3 Boehringer Ingelheim Scleroderma Diagnostics And Therapeutics Sales, Price, Revenue, Gross Margin
11.9.4 Boehringer Ingelheim Scleroderma Diagnostics And Therapeutics Sales by Region
11.10 Sanofi
11.10.1 Business Overview
11.10.2 Products Analysis
11.10.3 Sanofi Scleroderma Diagnostics And Therapeutics Sales, Price, Revenue, Gross Margin
11.10.4 Sanofi Scleroderma Diagnostics And Therapeutics Sales by Region
11.11 Cytori Therapeutics, Inc.
11.11.1 Business Overview
11.11.2 Products Analysis
11.11.3 Cytori Therapeutics, Inc. Scleroderma Diagnostics And Therapeutics Sales, Price, Revenue, Gross Margin
11.11.4 Cytori Therapeutics, Inc. Scleroderma Diagnostics And Therapeutics Sales by Region
13 Global Scleroderma Diagnostics And Therapeutics Market Forecast (2020-2028)
13.1 Global Scleroderma Diagnostics And Therapeutics Consumption Volume, Revenue and Price Forecast (2020-2028)
13.1.1 Global Scleroderma Diagnostics And Therapeutics Consumption Volume and Growth Rate Forecast (2020-2028)
13.1.2 Global Scleroderma Diagnostics And Therapeutics Value and Growth Rate Forecast (2020-2028)
13.1.3 Global Scleroderma Diagnostics And Therapeutics Price and Trend Forecast (2020-2028)
13.2 Global Scleroderma Diagnostics And Therapeutics Consumption Volume, Value and Growth Rate Forecast by Region (2020-2028)
13.2.1 Global Scleroderma Diagnostics And Therapeutics Consumption Volume and Growth Rate Forecast by Region (2020-2028)
13.2.2 Global Scleroderma Diagnostics And Therapeutics Value and Growth Rate Forecast by Region (2020-2028)
13.3 Global Scleroderma Diagnostics And Therapeutics Consumption Volume, Revenue and Price Forecast by Type (2020-2028)
13.3.1 Global Scleroderma Diagnostics And Therapeutics Consumption Forecast by Type (2020-2028)
13.3.2 Global Scleroderma Diagnostics And Therapeutics Revenue Forecast by Type (2020-2028)
13.3.3 Global Scleroderma Diagnostics And Therapeutics Price Forecast by Type (2020-2028)
13.4 Global Scleroderma Diagnostics And Therapeutics Consumption Volume Forecast by Application (2020-2028)
14 Research Conclusions
15 Appendix
15.1 Methodology
15.2 Research Data Source
